Andrade Robert Insider Trades

Insider Trading History

Track insider trading activity for Andrade Robert. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Fennec Pharmaceuticals
Fennec Pharmaceuticals FENC
CHIEF FINANCIAL OFFICER
Holding Value $2.98M 289,269 shares
Last Trade
May 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.9k 1,703 shares
$9.93
$10.30
Fennec Pharmaceuticals
Fennec Pharmaceuticals FENC
CHIEF FINANCIAL OFFICER
Holding Value $2.96M 287,566 shares
Last Trade
Apr 30, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$11.1k 1,703 shares
$6.49
$10.30
Fennec Pharmaceuticals
Fennec Pharmaceuticals FENC
CHIEF FINANCIAL OFFICER
Holding Value $2.82M 273,593 shares
Last Trade
Mar 31, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$104k 16,937 shares
$6.15
$10.30
Fennec Pharmaceuticals
Fennec Pharmaceuticals FENC
CHIEF FINANCIAL OFFICER
Holding Value $9.49M 921,045 shares
Last Trade
Mar 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$692k 120,000 shares
$5.77
$10.30
Fennec Pharmaceuticals
Fennec Pharmaceuticals FENC
CHIEF FINANCIAL OFFICER
Holding Value $2.94M 285,863 shares
Last Trade
Mar 28, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$72.5k 12,270 shares
$5.91
$10.30
Fennec Pharmaceuticals
Fennec Pharmaceuticals FENC
CHIEF FINANCIAL OFFICER
Holding Value $8.25M 801,045 shares
Last Trade
Mar 26, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$85.1k 13,072 shares
$6.51
$10.30
Fennec Pharmaceuticals
Fennec Pharmaceuticals FENC
CHIEF FINANCIAL OFFICER
Holding Value $2.64M 256,656 shares
Last Trade
Mar 26, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$85.1k 13,072 shares
$6.51
$10.30
Fennec Pharmaceuticals
Fennec Pharmaceuticals FENC
CHIEF FINANCIAL OFFICER
Holding Value $2.51M 243,584 shares
Last Trade
Feb 28, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.1k 1,191 shares
$8.49
$10.30
Fennec Pharmaceuticals
Fennec Pharmaceuticals FENC
CHIEF FINANCIAL OFFICER
Holding Value $8.39M 814,117 shares
Last Trade
Feb 18, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$22k 2,450 shares
$8.97
$10.30
Fennec Pharmaceuticals
Fennec Pharmaceuticals FENC
CHIEF FINANCIAL OFFICER
Holding Value $2.5M 242,393 shares
Last Trade
Feb 18, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$267k 29,735 shares
$8.97
$10.30
Fennec Pharmaceuticals
Fennec Pharmaceuticals FENC
CHIEF FINANCIAL OFFICER
Holding Value $2.19M 212,658 shares
Last Trade
Jan 31, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.8k 1,558 shares
$7.59
$10.30
Fennec Pharmaceuticals
Fennec Pharmaceuticals FENC
CHIEF FINANCIAL OFFICER
Holding Value $2.17M 211,100 shares
Last Trade
Jan 23, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$76.6k 10,000 shares
$7.66
$10.30
Fennec Pharmaceuticals
Fennec Pharmaceuticals FENC
CHIEF FINANCIAL OFFICER
Holding Value $8.41M 816,567 shares
Last Trade
Jan 23, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$76.6k 10,000 shares
$7.66
$10.30
Fennec Pharmaceuticals
Fennec Pharmaceuticals FENC
CHIEF FINANCIAL OFFICER
Holding Value $8.51M 826,567 shares
Last Trade
Jan 15, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$74.6k 10,000 shares
$7.46
$10.30
Fennec Pharmaceuticals
Fennec Pharmaceuticals FENC
CHIEF FINANCIAL OFFICER
Holding Value $2.07M 201,100 shares
Last Trade
Jan 15, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$74.6k 10,000 shares
$7.46
$10.30
Fennec Pharmaceuticals
Fennec Pharmaceuticals FENC
CHIEF FINANCIAL OFFICER
Holding Value $1.97M 191,100 shares
Last Trade
Jan 07, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$108k 14,184 shares
$7.60
$10.30
Fennec Pharmaceuticals
Fennec Pharmaceuticals FENC
CHIEF FINANCIAL OFFICER
Holding Value $8.62M 836,567 shares
Last Trade
Jan 07, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$108k 14,184 shares
$7.60
$10.30
Fennec Pharmaceuticals
Fennec Pharmaceuticals FENC
CHIEF FINANCIAL OFFICER
Holding Value $1.82M 176,916 shares
Last Trade
Dec 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.6k 1,382 shares
$7.70
$10.30
Fennec Pharmaceuticals
Fennec Pharmaceuticals FENC
CHIEF FINANCIAL OFFICER
Holding Value $1.81M 175,534 shares
Last Trade
Dec 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.8k 2,430 shares
$7.73
$10.30
Fennec Pharmaceuticals
Fennec Pharmaceuticals FENC
CHIEF FINANCIAL OFFICER
Holding Value $1.78M 173,104 shares
Last Trade
Oct 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.9k 2,430 shares
$8.20
$10.30

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up